Resources

Type of publications
Regions
Diseases

5192 results found

2022 ∙ Dzinamarira, Tafadzwa Murewanhema, Grant Chitungo, Itai Ngara, Bernard Nkambule, Sphamandla Josias Madziva, Roda Herrera, Helena Mukwenha, Solomon Cuadros, Diego F. Iradukunda, Patrick Gad Mashora, Moreblessing Tungwarara, Nigel Rwibasira, Gallican Nshogoza Musuka, Godfrey

Risk of mortality in HIV-infected COVID-19 patients: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Flacco, M. E. Acuti Martellucci, C. Baccolini, V. De Vito, C. Renzi, E. Villari, P. Manzoli, L.

Risk of reinfection and disease after SARS-CoV-2 primary infection: meta-analysis

  • Adults
  • Older adults
  • Adolescents
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Chu, D. K. Abrams, E. M. Golden, D. B. K. Blumenthal, K. G. Wolfson, A. R. Stone, C. A., Jr. Krantz, M. S. Shaker, M. Greenhawt, M.

Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Kechagias, K. S. Kalliala, I. Bowden, S. J. Athanasiou, A. Paraskevaidi, M. Paraskevaidis, E. Dillner, J. Nieminen, P. Strander, B. Sasieni, P. Veroniki, A. A. Kyrgiou, M.

Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis

  • All age groups
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Zhang, X. Xu, X. F. Jin, J.

Rotavirus vaccination and the risk of type 1 diabetes and celiac disease: A systematic review and meta-analysis

  • Newborn
  • Children
  • Adolescents
  • Rotavirus
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ SeyedAlinaghi, S. Karimi, A. Pashaei, Z. Afzalian, A. Mirzapour, P. Ghorbanzadeh, K. Ghasemzadeh, A. Dashti, M. Nazarian, N. Vahedi, F. Tantuoyir, M. M. Shamsabadi, A. Dadras, O. Mehraeen, E.

Safety and Adverse Events Related to COVID-19 mRNA Vaccines; a Systematic Review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Dadras, O. Mehraeen, E. Karimi, A. Tantuoyir, M. M. Afzalian, A. Nazarian, N. Mojdeganlou, H. Mirzapour, P. Shamsabadi, A. Dashti, M. Ghasemzadeh, A. Vahedi, F. Shobeiri, P. Pashaei, Z. SeyedAlinaghi, S.

Safety and Adverse Events Related to Inactivated COVID-19 Vaccines and Novavax;a Systematic Review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Mehta, N. Shah, S. Paudel, K. Chamlagain, R. Chhetri, S.

Safety and efficacy of coronavirus disease-19 vaccines in chronic kidney disease patients under maintenance hemodialysis: A systematic review

  • Older adults
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Tian, F. Yang, R.

Safety and Efficacy of COVID-19 Vaccines in Children and Adolescents: a Systematic Review of Randomized Controlled Trials

  • Newborn
  • Children
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Lopez-Olivo, M. A. Valerio, V. Karpes Matusevich, A. R. Brizio, M. Kwok, M. Geng, Y. Suarez-Almazor, M. E. Colmegna, I.

Safety and Efficacy of Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitors. Systematic Review with Meta-Analysis

  • All age groups
  • Influenza
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
Loading...